BRD2 and neoplasm: Our findings indicated that the DD pattern after early NAT, particularly at 1st-timepoint, was a tumor response marker independent of the size change in HR+/HER2− subtype; the SD pattern in HER2+ and TNBC after early NAT strongly indicated non-pCR.